866-997-4948(US-Canada Toll Free)

Chroma Therapeutics Ltd. - Product Pipeline Review - 2015

Published By :

Global Markets Direct

Published Date : Apr 2015

Category :

Pharmaceutical

No. of Pages : 27


Global Markets Directs, Chroma Therapeutics Ltd. Product Pipeline Review 2015, provides an overview of the Chroma Therapeutics Ltd.s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Chroma Therapeutics Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

  • The report provides brief overview of Chroma Therapeutics Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Chroma Therapeutics Ltd.s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones 
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement 
  • Latest news and deals relating to the Chroma Therapeutics Ltd.s pipeline products

Reasons to buy

  • Evaluate Chroma Therapeutics Ltd.s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Chroma Therapeutics Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Chroma Therapeutics Ltd.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Chroma Therapeutics Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Chroma Therapeutics Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Chroma Therapeutics Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues
Table of Contents

Table of Contents 2

List of Tables 4
List of Figures 4
Chroma Therapeutics Ltd. Snapshot 5
Chroma Therapeutics Ltd. Overview 5
Key Information 5
Key Facts 5
Chroma Therapeutics Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Chroma Therapeutics Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Out-Licensed Products 10
Out-Licensed Products/Combination Treatment Modalities 11
Chroma Therapeutics Ltd. - Pipeline Products Glance 12
Chroma Therapeutics Ltd. - Clinical Stage Pipeline Products 12
Phase I Products/Combination Treatment Modalities 12
Chroma Therapeutics Ltd. - Early Stage Pipeline Products 13
Discovery Products/Combination Treatment Modalities 13
Chroma Therapeutics Ltd. - Drug Profiles 14
tefinostat 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
CHR-5250 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
CHR-5623 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
CHR-6576 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Small Molecules for Inflammation 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Small Molecules to Antagonize CSF-1 Receptor for Oncology 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Chroma Therapeutics Ltd. - Pipeline Analysis 20
Chroma Therapeutics Ltd. - Pipeline Products by Target 20
Chroma Therapeutics Ltd. - Pipeline Products by Route of Administration 21
Chroma Therapeutics Ltd. - Pipeline Products by Molecule Type 22
Chroma Therapeutics Ltd. - Pipeline Products by Mechanism of Action 23
Chroma Therapeutics Ltd. - Dormant Projects 24
Chroma Therapeutics Ltd. - Locations And Subsidiaries 25
Head Office 25

Appendix 26
Methodology 26
Coverage 26
Secondary Research 26
Primary Research 26
Expert Panel Validation 26
Contact Us 26
Disclaimer 27

List of Table


Chroma Therapeutics Ltd., Key Information 5
Chroma Therapeutics Ltd., Key Facts 5
Chroma Therapeutics Ltd. - Pipeline by Indication, 2015 7
Chroma Therapeutics Ltd. - Pipeline by Stage of Development, 2015 8
Chroma Therapeutics Ltd. - Monotherapy Products in Pipeline, 2015 9
Chroma Therapeutics Ltd. - Out-Licensed Products in Pipeline, 2015 10
Chroma Therapeutics Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2015 11
Chroma Therapeutics Ltd. - Phase I, 2015 12
Chroma Therapeutics Ltd. - Discovery, 2015 13
Chroma Therapeutics Ltd. - Pipeline by Target, 2015 20
Chroma Therapeutics Ltd. - Pipeline by Route of Administration, 2015 21
Chroma Therapeutics Ltd. - Pipeline by Molecule Type, 2015 22
Chroma Therapeutics Ltd. - Pipeline Products by Mechanism of Action, 2015 23
Chroma Therapeutics Ltd. - Dormant Developmental Projects,2015 24

List of Chart


Chroma Therapeutics Ltd. - Pipeline by Top 10 Indication, 2015 7
Chroma Therapeutics Ltd. - Pipeline by Stage of Development, 2015 8
Chroma Therapeutics Ltd. - Monotherapy Products in Pipeline, 2015 9
Chroma Therapeutics Ltd. - Out-Licensed Products in Pipeline, 2015 10
Chroma Therapeutics Ltd. - Pipeline by Top 10 Target, 2015 20
Chroma Therapeutics Ltd. - Pipeline by Top 10 Route of Administration, 2015 21
Chroma Therapeutics Ltd. - Pipeline by Top 10 Molecule Type, 2015 22
Chroma Therapeutics Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015 23

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *